Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology

Absolute Antibody Ltd., an Oxford, UK-based company with a vision to make recombinant antibody technology accessible to all, and Kerafast Inc., a Boston, MA-based company with a mission to facilitate access to unique laboratory-made reagents, today announced a merger of the two companies. The merger brings together two companies with a shared commitment to improving the selection of research tools available to the scientific community.

ChartWise Medical Systems Receives KLAS CDI Software Category Leader Distinction for Third Consecutive Year

For the third consecutive year, ChartWise has been named a Category Leader in the Clinical Documentation Improvement Software segment in the 2018 Best in KLAS: Software & Services report. The prestigious and highly coveted Category Leader designation is reserved for vendor solutions that lead select market segments in which at least two products meet a minimum level of KLAS Konfidence.

Procured Health Is Now Lumere

My colleagues and I founded Procured Health in 2012 to assist hospitals and physicians in their efforts to make evidence-based and data-driven device selection and utilization decisions. Over time, as value-based care has become a reality, we’ve broadened our focus to more holistically guide clinicians and administrative leaders in not only devices but also in medication utilization. Additionally, we have launched new and innovative professional services. As a result, we felt our identity needed to better represent this expanded scope and mission. Watch a video to learn more about our unique clinical approach.

HealthiPASS secures $7.2M Series A to transform healthcare payments with greater transparency for patients

HealthiPASS, a patient check-in and payment technology provider that helps patients and providers combat the new healthcare reality of higher patient out of pocket expenses, announced it has raised a $7.2 million Series A funding round, led by FCA Venture Partners, with participation from venture firms from the Bay Area to Boston including: OCA Ventures, Healthy Ventures, HealthX Ventures, Waterline Ventures and a small group of strategic investors. The funds will be used to further innovate and expand the patient payments platform and sell into ambulatory healthcare settings across the country.